In this video, Ulrike Protzer, Director of the Institute of Virology at the Technical University of Munich and Helmholtz Munich and TherVacB Coordinator answers the question: What do we need to achieve an HBV Cure? Anti-virals, immune therapries, or both?
This is part of the new video series - HBV Cure FAQs: All you need to know to understand HBV research.
The HBV Cure FAQs are a new tool aimed at empowering the community by equipping them with the knowledge needed to understand research for a Hepatitis B (HBV) cure that is taking place for their benefit. It is a collection of short videos answering key questions relating to HBV cure research.
It is a product of an international consortium of organizations and expert institutions working in and around hepatitis B. The organizations involved are ICE-HBV, Hepatitis B Foundation, World Hepatitis Alliance, HepBCommunity.org, Australian Centre for Hepatitis Virology, TherVacB, IP-cureB, and the Canadian HBV Network.